Peter Mwaba

12.0k citations

111 papers · 6.4k indexed · 3 hit papers · h-index 44

Impact in

Infectious Diseases top 0.1%
- Tuberculosis Research and Epidemiology
- HIV/AIDS Research and Interventions
Epidemiology top 0.5%
- Pneumocystis jirovecii pneumonia detection and treatment
- Mycobacterium research and diagnosis
- Pneumonia and Respiratory Infections

Papers in ⓘ

Infectious Diseases 85
- Tuberculosis Research and Epidemiology 63
- HIV/AIDS Research and Interventions 11
Epidemiology 67
- Pneumocystis jirovecii pneumonia detection and treatment 35
- Pneumonia and Respiratory Infections 22
- Mycobacterium research and diagnosis 17

Co-authors: Alimuddin Zumla (77 shared papers)Matthew Bates (40 shared papers)Nathan Kapata (35 shared papers)Markus Maeurer (30 shared papers)Michael Höelscher (23 shared papers)Jeremiah Chakaya (9 shared papers)Sayoki Mfinanga (10 shared papers)Chifumbe Chintu (13 shared papers)
Journals: International Journal of Infectious Diseases (17 papers)The Lancet Infectious Diseases (11 papers)Tropical Medicine & International Health (11 papers)The Lancet (10 papers)Clinical Infectious Diseases (4 papers)
Partner nations: Zambia United Kingdom Germany

In The Last Decade

Peter Mwaba

109 papers receiving 6.2k citations

Hit Papers

align trajectories log scale

Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts 2021 · 673 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 International Journal of Infectious Diseases
2018 The Lancet Infectious Diseases
2013 The Lancet Infectious Diseases

Peers

Countries citing papers authored by Peter Mwaba

Since Specialization

Citations

This map shows the geographic impact of Peter Mwaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mwaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mwaba more than expected).

Fields of papers citing papers by Peter Mwaba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Mwaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mwaba. The network helps show where Peter Mwaba may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Mwaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Mwaba Line = papers co-authored together Peter Mwaba links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts International Journal of Infectious Diseases ·Jeremiah Chakaya, Mishal Khan, Francine Ntoumi, Eleni Aklillu, Razia Fatima, Peter Mwaba, Nathan Kapata, Sayoki Mfinanga, Seyed E. Hasnain, Patrick DMC Katoto, Andre Nyandwe Hamama Bulabula, Nadia A. Sam‐Agudu, Jean B. Nachega, Simon Tiberi, Timothy D. McHugh, Ibrahim Abubakar, Alimuddin Zumla Hit paper breakdown →	2021	673
2	Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test The Lancet Infectious Diseases ·Stephen D Lawn, Peter Mwaba, Matthew Bates, Amy S. Piatek, Heather Alexander, Ben J. Marais, Luís E. Cuevas, Timothy D. McHugh, Lynn S. Zijenah, Nathan Kapata, Ibrahim Abubakar, Ruth McNerney, Michael Höelscher, Ziad A. Memish, Giovanni Battista Migliori, Peter Kim, Markus Maeurer, Marco Schito, Alimuddin Zumla Hit paper breakdown →	2013	356
3	Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial The Lancet ·Grant Theron, Lynn S. Zijenah, Duncan Chanda, Petra Clowes, Andrea Rachow, Maia Lesosky, Wilbert Bara, Stanley Mungofa, Madhukar Pai, Michael Höelscher, David W. Dowdy, Alexander S. Pym, Peter Mwaba, Peter Mason, Jonny Peter, Keertan Dheda	2013	319
4	Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies The Lancet Infectious Diseases ·Simon Tiberi, Nelita du Plessis, Gerhard Walzl, M. Vjecha, Martin Rao, Francine Ntoumi, Sayoki Mfinanga, Nathan Kapata, Peter Mwaba, Timothy D. McHugh, Giuseppe Ippolito, Giovanni Battista Migliori, Markus Maeurer, Alimuddin Zumla Hit paper breakdown →	2018	271
5	Rapid Spread of Zika Virus in The Americas - Implications for Public Health Preparedness for Mass Gatherings at the 2016 Brazil Olympic Games International Journal of Infectious Diseases ·Eskild Petersen, Mary Wilson, Sok Touch, Brian McCloskey, Peter Mwaba, Matthew Bates, Osman Dar, Frank Mattes, Michael Kidd, Giuseppe Ippolito, Esam I. Azhar, Alimuddin Zumla	2016	263
6	Host-directed therapies for infectious diseases: current status, recent progress, and future prospects The Lancet Infectious Diseases ·Alimuddin Zumla, Martin Rao, Robert S. Wallis, Stefan H. E. Kaufmann, Roxana Rustomjee, Peter Mwaba, Cristina Vilaplana, Dorothy Yeboah‐Manu, Jeremiah Chakaya, Giuseppe Ippolito, Esam I. Azhar, Michael Höelscher, Markus Maeurer	2016	260
7	Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study The Lancet ·Chifumbe Chintu, Victor Mudenda, Sebastian Lucas, Andrew Nunn, Kennedy Lishimpi, Daniel Maswahu, Francis Kasolo, Peter Mwaba, Ganapati Bhat, Hiroshi Terunuma, Alimuddin Zumla	2002	255
8	Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers The Lancet Infectious Diseases ·Robert S. Wallis, Markus Maeurer, Peter Mwaba, Jeremiah Chakaya, Roxana Rustomjee, Giovanni Battista Migliori, Ben J. Marais, Marco Schito, Gavin Churchyard, Soumya Swaminathan, Michael Höelscher, Alimuddin Zumla	2016	205
9	Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial The Lancet ·Sayoki Mfinanga, Duncan Chanda, Sokoine Kivuyo, Lorna Guinness, Christian Bottomley, Victoria Simms, Carol Chijoka, Ayubu Masasi, Godfather Kimaro, Bernard Ngowi, Amos Kahwa, Peter Mwaba, Thomas S. Harrison, Saidi Egwaga, Shabbar Jaffar	2015	179
10	Twice weekly tuberculosis preventive therapy in HIV infection in Zambia AIDS ·Alwyn Mwinga, M Hosp, Peter Godfrey‐Faussett, Maria Quigley, Peter Mwaba, B N. Mugala, Osward M. Nyirenda, N. Luo, J. O. M. Pobee, Alison M. Elliott, Keith P. W. J. McAdam, John Porter	1998	170
11	Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies The Lancet Respiratory Medicine ·Alimuddin Zumla, Jeremiah Chakaya, Rosella Centis, Lia D’Ambrosio, Peter Mwaba, Matthew Bates, Nathan Kapata, Thomas Nyirenda, Duncan Chanda, Sayoki Mfinanga, Michael Höelscher, Markus Maeurer, Giovanni Battista Migliori	2015	159
12	Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions Postgraduate Medical Journal ·Peter Mwaba	2001	151
13	Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects The Lancet Infectious Diseases ·Alimuddin Zumla, Jaffar A. Al‐Tawfiq, Virve I. Enne, Michael Kidd, Christian Drosten, Judith Breuer, Marcel A. Müller, David S.C. Hui, Markus Maeurer, Matthew Bates, Peter Mwaba, Rafaat Alhakeem, Gregory C. Gray, Philippe Gautret, Abdullah A Al-Rabeeah, Ziad A. Memish, Vanya Gant	2014	128
14	Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era International Journal of Infectious Diseases ·Eskild Petersen, Ibrahim Abubakar, Chikwe Ihekweazu, Dominique Heymann, Francine Ntoumi, Lucille Blumberg, Danny Asogun, Victor Mukonka, Swaib A. Lule, Matthew Bates, Isobella Honeyborne, Sayoki Mfinanga, Peter Mwaba, Osman Dar, Francesco Vairo, Maowia M. Mukhtar, Richard Kock, Timothy D. McHugh, Giuseppe Ippolito, Alimuddin Zumla	2018	124
15	Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study The Lancet Infectious Diseases ·Matthew Bates, Justin O’Grady, Markus Maeurer, John Tembo, Lophina Chilukutu, Chishala Chabala, Richard Kasonde, Peter Mulota, Judith Mzyece, Mumba Chomba, Lukundo Mukonda, Maxwell Mumba, Nathan Kapata, Andrea Rachow, Petra Clowes, Michael Höelscher, Peter Mwaba, Alimuddin Zumla	2012	116
16	A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. PubMed ·Yusuf Ahmed, Peter Mwaba, Chifumbe Chintu, John M. Grange, Andrew Ustianowski, Alimuddin Zumla	1999	100
17	Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods The Lancet Infectious Diseases ·Clare Green, Jim F. Huggett, Elizabeth A. Talbot, Peter Mwaba, Klaus Reither, Alimuddin Zumla	2009	93
18	Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action The Lancet ·Ben J. Marais, Mario Raviǵlione, Peter R. Donald, Anthony Harries, Afrânio Lineu Kritski, Stephen M. Graham, Wafaa El‐Sadr, Mark Harrington, Gavin Churchyard, Peter Mwaba, Ian Sanne, Stefan H. E. Kaufmann, C. W. M. Whitty, Rifat Atun, Alimuddin Zumla	2010	88
19	Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments Current Opinion in Pulmonary Medicine ·Jonny Peter, Clare Green, Michael Höelscher, Peter Mwaba, Alimuddin Zumla, Keertan Dheda	2010	87
20	Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options The Lancet Infectious Diseases ·Alimuddin Zumla, Ziad A. Memish, Markus Maeurer, Matthew Bates, Peter Mwaba, Jaffar A. Al‐Tawfiq, David W. Denning, Frederick G. Hayden, David S.C. Hui	2014	79

About Peter Mwaba

Peter Mwaba is a scholar working on Infectious Diseases, Epidemiology, Virology, Pediatrics, Perinatology and Child Health and Medical Laboratory Technology, having authored 111 papers that have together received 6.4k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (63 papers), Pneumocystis jirovecii pneumonia detection and treatment (35 papers), Pneumonia and Respiratory Infections (22 papers), Mycobacterium research and diagnosis (17 papers), Diagnosis and treatment of tuberculosis (16 papers), HIV/AIDS Research and Interventions (11 papers), Global Maternal and Child Health (9 papers) and Infectious Diseases and Tuberculosis (8 papers). The work is most often cited by research in Infectious Diseases (4.4k citations), Epidemiology (3.4k citations), Virology (355 citations), Surgery (1.5k citations) and Molecular Medicine (143 citations). Peter Mwaba has collaborated with scholars based in Zambia, United Kingdom and Germany. Frequent co-authors include Alimuddin Zumla, Matthew Bates, Nathan Kapata, Markus Maeurer, Michael Höelscher, Jeremiah Chakaya, Sayoki Mfinanga, Chifumbe Chintu, Timothy D. McHugh and Giovanni Battista Migliori. Their work appears in journals such as International Journal of Infectious Diseases, The Lancet Infectious Diseases, Tropical Medicine & International Health, The Lancet and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact